Bilirrubina transcutânea em recém-nascidos pré-termo tardio, termo precoce e a termo em aleitamento materno exclusivo na primeira semana de vida

Detalhes bibliográficos
Autor(a) principal: Pereira, Dilma Carvalho [UNIFESP]
Data de Publicação: 2010
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: https://repositorio.unifesp.br/handle/11600/9143
Resumo: Background. Since most of newborn infants are fully breastfed in the first week of life, it is important to understand the behavior of physiological bilirubin values to guide mothers during hospital stay and follow them up after hospital discharge. Objective: To determine the increase and decrease of transcutaneous bilirubin (TcB) in late-preterm infants, early term and term newborns fully breastfed in the first week of life. Method: A prospective cohort study with 210 healthy, fully breastfed neonates born from March/09-March10, with the following criteria: 35-39 weeks of gestation, birth weight >2000g, Apgar 5 min >7, without any congenital malformation or hemolytic disease. All were at rooming-in before 6 hours of life. Each newborn had sternum TcB (JM 103 Minolta) and body weight measured at 24, 48, 96 , 144 and 192 hours of life. The TcB was considered until initiation of phototherapy, according to AAP 2004. TcB mean estimates were compared by ANOVA repeated measures between late preterm (n=60), early term (n=60), and full term (n=90) newborn infants. Maternal and neonatal characteristics were compared between groups by one-way ANOVA, Kruskal Wallis, X2, and Fisher test (significant p<0.05). Results: The 3 groups were similar regarding to: maternal age 23+7 years, first gestation 54%, hypertension/diabetes 12%, vaginal delivery 70%, male 49%, ABO incompatibility 10%, breastfed in the 1st h after birth - 57%, and the highest weight loss 5.9&#61617;2.0% (maximum 11%) at 48th hour. However, phototherapy was applied in 22% late pre-term, 5% early term, and 1% of term neonates (p<0.001). BTc mean estimates in PTT, TP e T were, respectively, at 24h – 4.5; 3.9; 3.1 mg/dL (p=0,037), at 48h – 7.4; 6.3; 4.7 mg/dL (p<0.001), at 96h – 7.8; 7.0; 4.4 mg/dL (p<0.001), and at 192h – 4.9; 4.9 and 2.5 mg/dL (p<0,001). Late preterm and early term infants had similar TcB levels, around 2.0-3.0 mg/dL higher than in term newborns until 192 hours of life. A TcB decrease at 0.02-0.03 mg/dL/hour was found between 96 and 192h of life in LPT and ET. Late preterm and early term patients had similar TcB levels, around 2.0- 3.0 mg/dL higher than in term newborns until 192 hours of life. A TcB decrease 0.02-0.03 mg/dL/hour was found between 96 and 192h of life in the 3 groups. Conclusion: Fully breastfed late preterm and early term newborn babies have similar increase and decrease of TcB levels, but higher than in term newborn infants, in the first week of life.
id UFSP_ae1115131d85bdf1e216877acd229643
oai_identifier_str oai:repositorio.unifesp.br/:11600/9143
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Bilirrubina transcutânea em recém-nascidos pré-termo tardio, termo precoce e a termo em aleitamento materno exclusivo na primeira semana de vidaTranscutaneous bilirubin in fully breastfed late preterm, early term, and full-term newborn infants in the first week of lifeAleitamento maternoHiperbilirrubinemiaRecém-nascidosIcteríciaBackground. Since most of newborn infants are fully breastfed in the first week of life, it is important to understand the behavior of physiological bilirubin values to guide mothers during hospital stay and follow them up after hospital discharge. Objective: To determine the increase and decrease of transcutaneous bilirubin (TcB) in late-preterm infants, early term and term newborns fully breastfed in the first week of life. Method: A prospective cohort study with 210 healthy, fully breastfed neonates born from March/09-March10, with the following criteria: 35-39 weeks of gestation, birth weight >2000g, Apgar 5 min >7, without any congenital malformation or hemolytic disease. All were at rooming-in before 6 hours of life. Each newborn had sternum TcB (JM 103 Minolta) and body weight measured at 24, 48, 96 , 144 and 192 hours of life. The TcB was considered until initiation of phototherapy, according to AAP 2004. TcB mean estimates were compared by ANOVA repeated measures between late preterm (n=60), early term (n=60), and full term (n=90) newborn infants. Maternal and neonatal characteristics were compared between groups by one-way ANOVA, Kruskal Wallis, X2, and Fisher test (significant p<0.05). Results: The 3 groups were similar regarding to: maternal age 23+7 years, first gestation 54%, hypertension/diabetes 12%, vaginal delivery 70%, male 49%, ABO incompatibility 10%, breastfed in the 1st h after birth - 57%, and the highest weight loss 5.9&#61617;2.0% (maximum 11%) at 48th hour. However, phototherapy was applied in 22% late pre-term, 5% early term, and 1% of term neonates (p<0.001). BTc mean estimates in PTT, TP e T were, respectively, at 24h – 4.5; 3.9; 3.1 mg/dL (p=0,037), at 48h – 7.4; 6.3; 4.7 mg/dL (p<0.001), at 96h – 7.8; 7.0; 4.4 mg/dL (p<0.001), and at 192h – 4.9; 4.9 and 2.5 mg/dL (p<0,001). Late preterm and early term infants had similar TcB levels, around 2.0-3.0 mg/dL higher than in term newborns until 192 hours of life. A TcB decrease at 0.02-0.03 mg/dL/hour was found between 96 and 192h of life in LPT and ET. Late preterm and early term patients had similar TcB levels, around 2.0- 3.0 mg/dL higher than in term newborns until 192 hours of life. A TcB decrease 0.02-0.03 mg/dL/hour was found between 96 and 192h of life in the 3 groups. Conclusion: Fully breastfed late preterm and early term newborn babies have similar increase and decrease of TcB levels, but higher than in term newborn infants, in the first week of life.Introdução. Dificuldade na amamentação com perda de peso elevada está associada à hiperbilirrubinemia e encefalopatia em prematuros (PT) tardios e recém-nascidos (RN) de termo nos primeiros dias de vida. Uma vez que, no Brasil, 92% dos RN recebem aleitamento materno no primeiro mês, estudar a influência da idade gestacional (IG) sobre a bilirrubinemia pode auxiliar na orientação da equipe de saúde e dos pais. Objetivo. Determinar a ascensão e queda da bilirrubina transcutânea (BTc) em RN PT tardios, a termo precoce e a termo em aleitamento materno exclusivo na primeira semana de vida. Método. Coorte prospectiva constituída de 210 pacientes nascidos em hospital público, de mar/2009-mar/2010, com os seguintes critérios: IG 35 a 41 semanas completas, peso ao nascer >2000g, Apgar >7 no 5º minuto, sem malformação congênita/doença hemolítica Rh, em alojamento conjunto antes de 6h de vida e aleitamento materno exclusivo até o 8º dia. Na 24ª e 48ª h de vida durante a internação e na 96ª, 144ª e 192ªh no domicílio, a Btc (JM 103 Minolta) foi mensurada no esterno e o peso foi determinado em balança digital. A BTc foi considerada até a indicação de fototerapia. As estimativas médias de BTc foram comparadas por ANOVA com medidas repetidas entre PT tardios (PTT) de 35-36 semanas (n=60), termo precoce (TP) de 37 e 38 semanas (n=60) e de termo (T) de 39 a 41 semanas (n=90). Características maternas e neonatais foram comparadas com one-way ANOVA, Kruskal Wallis, qui-quadrado e teste exato de Fisher, considerando-se significante p<0,05. Resultados. Os 3 grupos foram semelhantes quanto à idade materna 23+7 anos, cor parda/negra 85%, primiparidade 54%, hipertensão/diabetes 12%, parto vaginal 70%, ocitocina 64%, peso adequado/IG 83%, sexo masculino 49%, incompatibilidade ABO 10%, mamada na 1ª hora 57% e perda de peso na 48ªh de vida 5,9+2,0% (máximo 11,1%), mas foram diferentes quanto ao uso de fototerapia (PTT-22%; TP-5%; T-1%; p<0,001). A BTc apresentou evolução diferente nas três faixas de IG (p<0,001) e ao longo do tempo (p<0,001). A estimativa média da BTc nos grupos PTT, TP e T foi, respectivamente, com 24 horas de vida - 4,5; 3,9 e 3,1 mg/dL (p=0,037), 48 horas - 7,4; 6,3 e 4,7 mg/dL (p<0,001), 96 horas - 7,8; 7,0 e 4,4 mg/dL (p<0,001), 144 horas - 6,2; 5,8 e 3,2 mg/dL (p<0,001) e 192 horas - 4,9; 4,9; e 2,5 mg/dL (p<0,001). RN PT tardios e RN de termo precoce apresentam perfil médio de BTc entre 2,0 e 3,0 mg/dL acima do perfil médio de RN termo com 48, 96, 144, e 192 horas de vida. A BTc aumentou até a 96ª hora e diminuiu 0,02-0,03 mg/dL/hora entre 96 e 192 horas de vida nos três grupos. Conclusão. RN PT tardios e RN a termo precoce em aleitamento materno exclusivo, apresentam ascensão e decréscimo semelhantes de bilirrubina transcutânea, mas com níveis superiores em relação aos RN de termo na primeira semana de vida.TEDEBV UNIFESP: Teses e dissertaçõesUniversidade Federal de São Paulo (UNIFESP)Almeida, Maria Fernanda Branco de [UNIFESP]Universidade Federal de São Paulo (UNIFESP)Pereira, Dilma Carvalho [UNIFESP]2015-07-22T20:49:39Z2015-07-22T20:49:39Z2010-11-24info:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/publishedVersion70 p.application/pdfPEREIRA, Dilma Carvalho. Bilirrubina transcutânea em recém-nascidos pré-termo tardio, termo precoce e a termo em aleitamento materno exclusivo na primeira semana de vida. 2010. Dissertação (Mestrado) - Universidade Federal de São Paulo (UNIFESP), São Paulo, 2010.Publico-320.pdfhttps://repositorio.unifesp.br/handle/11600/9143porinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-03T10:29:54Zoai:repositorio.unifesp.br/:11600/9143Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-03T10:29:54Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Bilirrubina transcutânea em recém-nascidos pré-termo tardio, termo precoce e a termo em aleitamento materno exclusivo na primeira semana de vida
Transcutaneous bilirubin in fully breastfed late preterm, early term, and full-term newborn infants in the first week of life
title Bilirrubina transcutânea em recém-nascidos pré-termo tardio, termo precoce e a termo em aleitamento materno exclusivo na primeira semana de vida
spellingShingle Bilirrubina transcutânea em recém-nascidos pré-termo tardio, termo precoce e a termo em aleitamento materno exclusivo na primeira semana de vida
Pereira, Dilma Carvalho [UNIFESP]
Aleitamento materno
Hiperbilirrubinemia
Recém-nascidos
Icterícia
title_short Bilirrubina transcutânea em recém-nascidos pré-termo tardio, termo precoce e a termo em aleitamento materno exclusivo na primeira semana de vida
title_full Bilirrubina transcutânea em recém-nascidos pré-termo tardio, termo precoce e a termo em aleitamento materno exclusivo na primeira semana de vida
title_fullStr Bilirrubina transcutânea em recém-nascidos pré-termo tardio, termo precoce e a termo em aleitamento materno exclusivo na primeira semana de vida
title_full_unstemmed Bilirrubina transcutânea em recém-nascidos pré-termo tardio, termo precoce e a termo em aleitamento materno exclusivo na primeira semana de vida
title_sort Bilirrubina transcutânea em recém-nascidos pré-termo tardio, termo precoce e a termo em aleitamento materno exclusivo na primeira semana de vida
author Pereira, Dilma Carvalho [UNIFESP]
author_facet Pereira, Dilma Carvalho [UNIFESP]
author_role author
dc.contributor.none.fl_str_mv Almeida, Maria Fernanda Branco de [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Pereira, Dilma Carvalho [UNIFESP]
dc.subject.por.fl_str_mv Aleitamento materno
Hiperbilirrubinemia
Recém-nascidos
Icterícia
topic Aleitamento materno
Hiperbilirrubinemia
Recém-nascidos
Icterícia
description Background. Since most of newborn infants are fully breastfed in the first week of life, it is important to understand the behavior of physiological bilirubin values to guide mothers during hospital stay and follow them up after hospital discharge. Objective: To determine the increase and decrease of transcutaneous bilirubin (TcB) in late-preterm infants, early term and term newborns fully breastfed in the first week of life. Method: A prospective cohort study with 210 healthy, fully breastfed neonates born from March/09-March10, with the following criteria: 35-39 weeks of gestation, birth weight >2000g, Apgar 5 min >7, without any congenital malformation or hemolytic disease. All were at rooming-in before 6 hours of life. Each newborn had sternum TcB (JM 103 Minolta) and body weight measured at 24, 48, 96 , 144 and 192 hours of life. The TcB was considered until initiation of phototherapy, according to AAP 2004. TcB mean estimates were compared by ANOVA repeated measures between late preterm (n=60), early term (n=60), and full term (n=90) newborn infants. Maternal and neonatal characteristics were compared between groups by one-way ANOVA, Kruskal Wallis, X2, and Fisher test (significant p<0.05). Results: The 3 groups were similar regarding to: maternal age 23+7 years, first gestation 54%, hypertension/diabetes 12%, vaginal delivery 70%, male 49%, ABO incompatibility 10%, breastfed in the 1st h after birth - 57%, and the highest weight loss 5.9&#61617;2.0% (maximum 11%) at 48th hour. However, phototherapy was applied in 22% late pre-term, 5% early term, and 1% of term neonates (p<0.001). BTc mean estimates in PTT, TP e T were, respectively, at 24h – 4.5; 3.9; 3.1 mg/dL (p=0,037), at 48h – 7.4; 6.3; 4.7 mg/dL (p<0.001), at 96h – 7.8; 7.0; 4.4 mg/dL (p<0.001), and at 192h – 4.9; 4.9 and 2.5 mg/dL (p<0,001). Late preterm and early term infants had similar TcB levels, around 2.0-3.0 mg/dL higher than in term newborns until 192 hours of life. A TcB decrease at 0.02-0.03 mg/dL/hour was found between 96 and 192h of life in LPT and ET. Late preterm and early term patients had similar TcB levels, around 2.0- 3.0 mg/dL higher than in term newborns until 192 hours of life. A TcB decrease 0.02-0.03 mg/dL/hour was found between 96 and 192h of life in the 3 groups. Conclusion: Fully breastfed late preterm and early term newborn babies have similar increase and decrease of TcB levels, but higher than in term newborn infants, in the first week of life.
publishDate 2010
dc.date.none.fl_str_mv 2010-11-24
2015-07-22T20:49:39Z
2015-07-22T20:49:39Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv PEREIRA, Dilma Carvalho. Bilirrubina transcutânea em recém-nascidos pré-termo tardio, termo precoce e a termo em aleitamento materno exclusivo na primeira semana de vida. 2010. Dissertação (Mestrado) - Universidade Federal de São Paulo (UNIFESP), São Paulo, 2010.
Publico-320.pdf
https://repositorio.unifesp.br/handle/11600/9143
identifier_str_mv PEREIRA, Dilma Carvalho. Bilirrubina transcutânea em recém-nascidos pré-termo tardio, termo precoce e a termo em aleitamento materno exclusivo na primeira semana de vida. 2010. Dissertação (Mestrado) - Universidade Federal de São Paulo (UNIFESP), São Paulo, 2010.
Publico-320.pdf
url https://repositorio.unifesp.br/handle/11600/9143
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 70 p.
application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
publisher.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268357810061312